Decentralized and Direct-To-Patient Trials: Care Access CEO & Co-Founder Shares Insights at Future Trials Conference
Care Access CEO and Co-Founder Ahmad Namvargolian is on a mission to remove barriers to clinical trials for sponsors, physicians and patients, and to make research studies accessible for all. This mission was put to the test in the spring of 2020, when the COVID-19 pandemic sent the world screeching to a halt.
Read More